Newsroom

Advancements in Technology in Food Safety and Environmental Monitoring: Bringing Innovation to the Table

May 4, 2022 11:30:00 AM / by Holly Young posted in Gii-Sens, Graphene Applications

0 Comments

Food safety is of paramount importance in a world where the demand for food is increasing rapidly due to a growing population. Food deemed unsafe for consumption poses a hazard to human health, as a result, food production companies responsible for hazardous outbreaks can suffer devastating consequences. There is a need for technology that can effectively monitor food safety and the environment in which food is grown to ensure that it is safe for consumption.

Read More

The Emergence of Electrochemical Biosensors as a Tool for Food Safety and Environmental Monitoring

Apr 20, 2022 2:30:00 PM / by Karolina Künnapuu posted in Gii-Sens

0 Comments

Contamination of food and drinking water is a significant source of disease transmission around the world. As demand for food rises along with the increasing global population, so does the need for efficient and affordable methods for food and environmental monitoring that are suitable for use in both developed as well as developing countries. Continuous monitoring of food safety parameters is essential to ensure that food products reaching consumers are of high quality and fit to eat, as well as for helping to reduce food waste. Environmental monitoring ensures the quality of water, soil, weather, and livestock involved in food production as well as the cleanliness of drinking water. Moreover, environmental monitoring can reduce environmental pollution and help fight climate change. 

Read More

University of Bath Press Release - Novel Chemical Glucose Sensing Method based on Boronic Acids and Graphene Foam

Feb 3, 2022 11:00:00 AM / by Caitlin Ho posted in Gii-Sens, 3D Graphene

0 Comments

 

Researchers at the University of Bath working in collaboration with industrial partner, Integrated Graphene, have developed a new sensing technique based on graphene foam for the detection of glucose levels in the blood. Since it is a chemical sensor instead of being enzyme-based, the new technology is robust, has a long shelf-life and can be tuned to detect lower glucose concentrations than current systems.

Read More

How can Integrated Graphene Customise to Your Needs?

Dec 8, 2021 11:30:00 AM / by Caitlin Ho posted in Gii-Sens

0 Comments

 

 

At Integrated Graphene, we have invented and patented a revolutionary design for manufacture process to produce high-performing and commercially viable pure 3D Graphene Foam directly onto desired substrate, in seconds. This means we can have an open production method to customise Gii-Sens® for specific designs and demand. 

Read More

5 Reasons Why You Should Be Using the New Gii-Sens+® Electrodes

Oct 13, 2021 11:00:00 AM / by Sean Lightheart posted in Gii-Sens

0 Comments

 

Following the launch of Gii-Sens, the world's first 3D Graphene Foam sensing electrode, with our 98% pure graphene Gii, comes the new, pre-functionalised Gii-Sens+ sensors available in Carboxyl (COOH) and N-Hydroxysuccinimide (NHS) groups. The initial response for Gii-Sens was well received and we have built on early feedback to deliver the next generation of our products. This feedback has shown a requirement for the opportunity to work with new technique to enable faster workflows, and save time. This is where the development of Gii-Sens+ was born, with the ability to easily purchase functionalised electrodes, removing the inconvenience of the preparation by perfecting surface modification and recognition molecule immobilisation to ensure you get the most out of your antibodies.

Read More

Press Release - Integrated Graphene launch 2nd Graphene Product for Medical Diagnostics Market

Sep 30, 2021 1:52:25 PM / by Sean Lightheart posted in Gii-Sens

0 Comments

Stirling, Scotland - 30th September – Integrated Graphene, an advanced materials manufacturer, today soft-launched their new Gii-Sens+ modified-graphene sensing platform which will be available internationally. As part of the Gii-Sens+ product line, sensors functionalised by both Carboxyl (COOH) and N-Hydroxysuccinimide (NHS) groups are now available, being introduced to help medical diagnostic developers exploit the superlative sensory properties of graphene via surface modification to then make the biorecognition molecule immobilisation easier. 

Read More

Graphene Sensing to Enable Bioassay Protocol Reduction

Jul 7, 2021 12:04:28 PM / by Luca Vita posted in Gii-Sens, 3D Graphene Foam

0 Comments

Large-scale diagnostic laboratories have proven very efficient in delivering test results world-wide and allowing us to diagnose a large array of diseases and change the way we deliver healthcare. Despite offering accurate results, these laboratories rely on experienced staff undertaking lengthy protocols, with large volumes of reagents, that drive up costs and ultimately leading to long result turnaround times.

Read More

Graphene Sensing to Overcome Limits of Detection in Diagnostics

Jun 16, 2021 10:53:30 AM / by Carla Elizondo posted in Gii-Sens, Point of Care

0 Comments

 

With a multitude of applications, from quality control to disease diagnostics, an effective bioassay is a vital tool in any scientist’s arsenal. However, like any ever-developing technology, bioassays come with their limitations, one of the most prominent being the limit of detection (LoD).

Read More

Graphene Sensing to Overcome Assay Background Noise

May 19, 2021 12:43:24 PM / by Sean Lightheart posted in Gii-Sens, 3D Graphene Foam

0 Comments

Despite rigorous optimisation, bioassay performance runs the risk of being compromised by background noise. For reliable results, it is essential that background noise is both accurately distinguished from true signal and minimised to prevent its interference with the detection of low-concentration analytes. 

Read More

How do you ensure a successful route to market for point of care testing?

May 5, 2021 9:44:04 AM / by Carla Elizondo posted in Gii-Sens, Point of Care

0 Comments

Bridging the bench to bedside gap with point of care testing 

One barrier to closing the bench to bedside gap is the burden of large-scale laboratory testing limiting access to diagnostic testing at the point of need in a range of sectors, from human diagnostics to agriculture. 

Read More
Content not found